Sections
| Title | Starting Page | Number of Pages |
|---|
| Table of Contents | 2 | 3 |
| List of Tables | 3 | 1 |
| List of Figures | 4 | 1 |
| TapImmune Inc., Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 2016 | 4 | 2 |
| TapImmune Inc., Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 2016 | 6 | 1 |
| TapImmune Inc., Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 2016 | 7 | 1 |
| TapImmune Inc., Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 2016 | 8 | 1 |
| TapImmune Inc., Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016 | 9 | 1 |
| TapImmune Inc., Pharmaceuticals &Healthcare, Deal Details | 10 | 18 |
| Partnerships | 10 | 1 |
| Vaccine &Gene Therapy Institute Enters into Research Agreement with TapImmune | 10 | 1 |
| TapImmune Enters Into Research Agreement With Mayo Clinic | 11 | 1 |
| Licensing Agreements | 12 | 1 |
| TapImmune Exercises Option for Licensing Agreement with Mayo Clinic | 12 | 1 |
| TapImmune Exercises Option for Licensing Agreement with Mayo Clinic for HER2/neu Vaccine Technology | 13 | 1 |
| Equity Offering | 14 | 1 |
| TapImmune to Raise USD6 Million in Private Placement of Shares upon Exercise of Warrants | 14 | 2 |
| TapImmune to Raise USD2.5 Million in Private Placement of Units | 16 | 2 |
| TapImmune Raises USD2.5 Million in Private Placement of Shares upon Exercise of Warrants | 18 | 1 |
| TapImmune to Raise USD5 Million in Private Placement of Shares upon Exercise of Warrants | 19 | 1 |
| TapImmune to Raise USD1.5 Million in Private Placement of Units | 20 | 2 |
| TapImmune to Raise USD2 Million in Private Placement of Shares | 22 | 2 |
| TapImmune Completes Private Placement For US$1.16 Million | 24 | 1 |
| TapImmune Completes Private Placement For US$1.3 Million | 25 | 1 |
| Debt Offering | 26 | 1 |
| TapImmune Completes Private Placement Of Senior Secured Convertible Notes For US$1.5 Million | 26 | 2 |
| TapImmune Inc. - Key Competitors | 28 | 1 |
| Key Employees | 29 | 1 |
| Locations And Subsidiaries | 30 | 1 |
| Head Office | 30 | 1 |
| Appendix | 31 | 1 |
| Methodology | 31 | 1 |
| About GlobalData | 31 | 1 |
| Contact Us | 31 | 1 |
| Disclaimer | 31 | 1 |